InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Laviolette Paul A, 董事. Director active across 3 companies, notably Edwards Lifesciences Corp. Cumulatively, 7 filings have been logged. History available since 5 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Laviolette Paul A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,528 股0Common StockSEC:0001225208-25-004953:0
3,055 股0Common StockSEC:0001225208-24-005895:0
2,803 股0Common StockSEC:0001225208-23-005907:0
2,300 股0Common StockSEC:0001225208-22-006589:0
1,744,017 股Common StockSEC:0001493152-21-030847:0
13,846 股0Common StockSEC:0001209191-21-045181:0
2,615 股0Common StockSEC:0001225208-21-007761:0
7 条申报中的 7 条
About Laviolette Paul A
Paul A. Lavoilette is a Director at Edwards Lifesciences Corp, Asensus Surgical, Inc., and Misonix Inc. In this role, he provides expertise in corporate governance and strategy. Lavoilette plays an important role in assessing performance and making strategic decisions within the boards of these companies. His experience in the healthcare and medical technology sectors is an asset to the companies he serves.
